acalabrutinib - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
CALQUENCE acalabrutinib 100 mg capsule blister pack AUST R: 321419Active ingredients:
acalabrutinib
Dosage form:
Capsule, hard
Sponsor:
AstraZeneca Pty Ltd
Phone:
1800 805 342
|
Deletion from market:
30 Jun 2024
|
Shortage status:
To be discontinued
Availability:
Unavailable
Reason:
Transport / Logistic issues / Storage capacity issues
Management action:
Sponsor is transitioning to CALQUENCE acalabrutinib (as maleate) 100 mg film-coated tablet blister pack (AUST R 377410) from July 2024
|